Background The transforming growth factor (TGF)-β superfamily comprises cytokines such as TGF-β and Bone Morphogenetic Proteins (BMPs), which have a critical role in a multitude of biological processes. In breast cancer, high levels of TGF-β are associated with poor outcome, whereas inhibition of TGF-β-signaling reduces metastasis. In contrast, BMP-7 inhibits bone metastasis of breast cancer cells.
the primary tumor, but from distant metastasis. High morbidity is especially caused by bone metastasis. In order to metastasize a cancer cell must shed many of its epithelial characteristics, invade the surrounding tissue to enter the circulation, subsequently survive in the circulation, extravasate and proliferate in the metastatic niche [1] . Invasion is therefore a key step in the metastatic cascade. Several classes of proteins have been shown to play a role in this process, such as the integrin family of adhesion receptors. Integrins, which consist of an α and β subunit, are important for adhesion of cells to the extracellular matrix [2] . Cancer cells express specific integrin combinations, whose signaling favors migration and invasion [3] . Integrin α v β 3 is strongly expressed by breast cancer cells, especially by cells residing in bone metastasis [4] . Its expression promotes bone metastasis of breast cancer cells [5, 6] , whereas inhibition of α v β 3 diminishes their osteotropism [7] .
Transforming Growth Factor (TGF)-β has a dual role in carcinogenesis. In the early stages it has a growth inhibitory and pro-apoptotic effect, whereas at the later stages of cancer, TGF-β promotes invasion and metastasis [8, 9] . In line with its stimulatory role in cancer progression, TGF-β is frequently overexpressed in breast cancer and its expression correlates with poor prognosis and metastasis [10] [11] [12] . Moreover, studies in mouse models have demonstrated that inhibition of TGF-β-signaling in breast cancer cells reduces metastasis [13] [14] [15] [16] .
TGF-β and Bone Morphogenetic Proteins (BMPs) signal via comparable mechanisms. Upon binding of the ligand, the type II receptor phosphorylates the type I receptor. The type I receptor, in turn, phosphorylates the receptorregulated (R)-Sma and Mad related gene product (Smad). Phosphorylated R-Smads form heteromeric complexes with the common mediator Smad (Co-Smad) Smad4. These complexes then translocate to the nucleus, where they regulate transcription of target genes in collaboration with other transcription factors [17] . In most cell types, TGF-β signals through the TGF-β receptor type II (TβRII) and the TGF-β type I receptor, also termed activin receptor-like kinase 5 (ALK5). ALK5 mediates the phosphorylation of Smad2 and Smad3 [18] . BMPs signal through their specific BMP receptor type II (BMPRII) and BMP type I receptors (BMPRI) which induce the activation of Smad1, Smad5 and Smad8 [19] . In addition to the previously described Smad pathways, receptor activation results in activation of several other non-Smad signaling pathways, for example Mitogen Activated Protein Kinase (MAPK) pathways [20] .
TGF-β is thought to be pro-invasive by inducing epithelial-to-mesenchymal transition (EMT). During this process, carcinoma cells acquire a more motile, mesenchymal phenotype [21] . In normal breast and kidney epithelial cells BMP-7 can inhibit TGF-β-induced EMT [22] ; BMP-7 has also been shown to inhibit EMT and bone metastasis in breast and prostate tumors [23, 24] . However, the effect of BMP-7 on tumor invasion is unknown.
Previously, we have set up a spheroid invasion model to study TGF-β-induced invasion [25, 26] . In this assay, spheroids made from MCF10A series of cell lines invade in response to TGF-β. The MCF10A cell lines originate from MCF10A1, a spontaneously immortalized breast cell line [27] . This cell line was transformed with oncogenic RAS, resulting in MCF10AT (hereafter referred to as M-II), which forms premalignant lesions in mice that upon grafting progressed into carcinoma [28] . From these carcinomas MCF10CA1a was isolated (hereafter referred to as M-IV), which metastatasizes to the lung [29] . Using these cell lines in the invasion assay, we have shown the importance of Smad signaling for TGF-β-induced invasion [25] . In the current paper, we have analyzed the role of BMP-7. We show that BMP-7 can inhibit TGF-β-induced invasion through inhibition of TGF-β-induced integrin β 3 expression.
Materials and methods

Cell culture
MCF10AT (M-II) and MCF10CA1a (M-IV) were obtained from Dr. Fred Miller (Barbara Ann Karmanos Cancer Institute, Detroit, USA) and maintained as described [25] .
Invasion spheroid assays
The invasion spheroid assay was performed essentially as described in [25] . Briefly, 10 3 cells were allowed to form spheroids and spheroids were embedded in a 1:1 collagen: methocel mixture onto a collagen coated plate. Recombinant human TGF-β3 (a generous gift of Dr. K. Iwata, OSI Pharmaceuticals, Inc, New York, USA), BMP-6, BMP-7 (both a kind gift of K. Sampath, Creative Biomolecules, Inc, Hoptinton, USA), isotype control antibody (Santa Cruz) or human BMP-7 neutralizing antibody (R&D Systems) were added directly into the collagen:methocel mixture at 4°C. After 30 min incubation at 37°C medium was added on top of the collagen, either containing no solvent, DMSO or the integrin inhibitor GLPG0187 (Galapagos NV, Mechelen, Belgium). Invasion was monitored during the next 2 days and quantified by measuring the area using ImageJ or Adobe Photoshop.
Western blot analysis
2×10
5 cells were seeded onto a six well plate and 1 day later starved for 16 h in medium containing 2.5% horse serum (Gibco), 10 ng/ml epidermal growth factor (EGF) (Upstate), 50 ng/ml cholera toxin (Calbiochem), 0.25 μg/ml hydrocortisone (Sigma), 5 μg/ml insulin (Sigma), 100 U/ml penicillin and 50 μg/ml streptomycin (Gibco). After starvation, cells were stimulated, washed and lysed in RIPA buffer or sample buffer. Lysates were subjected to SDS-PAGE & Western blotting. Phosphorylation of Smad1/5/8 was detected by anti phospho-Smad1 antibody as described before [30] . Phospho-Smad2 antibody was purchased from Cell Signaling. Total Smad1 antibody was from Zymed.
Transcriptional reporter assay
1×10
5 cells were seeded onto a 24-well plate and 1 day later transfected for 4 h with the reporters CAGA 12 -Luc [31] or BRE-Luc [32] using either Lipofectamine 2000 or LTX (Invitrogen). An expression plasmid for β-galactosidase was co-transfected and used to correct for transfection efficiency. One day after transfection, cells were serum starved overnight in medium containing 2.5% horse serum (Gibco), 10 ng/ml epidermal growth factor (EGF) (Upstate), 50 ng/ml cholera toxin (Calbiochem), 0.25 μg/ml hydrocortisone (Sigma), 5 μg/ml insulin (Sigma), 100 U/ml penicillin and 50 μg/ml streptomycin (Gibco) and subsequently stimulated for 8 h. Luciferase and β-galactosidase activity were determined as previously described [31] . Each transfection was carried out in triplicate and representative experiments are shown.
2.5 RNA isolation, cDNA synthesis and quantitative PCR RNA isolation, cDNA synthesis and quantitative PCR (Q-PCR) were performed as previously described [25] . The following primers were used: acidic ribosomal phosphoprotein (ARP) forward 5′-CACCATTGAAATCCTGAGT GATGT -3′ and reverse 5′-TGACCAGCCGAAAGGA GAAG -3′; matrix metalloproteinase 2 (MMP2) forward 5′-AGATGCCTGGAATGCCAT-3′ and reverse 5′ -GGTTCTCCAGCTTCAGGTAAT-3′; integrin α v forward 5′-CAGGCTTGCAACCCATTCTT-3′ and reverse 5′-GAATGTGAGCCTGTCGACTAATGTT-3′; integrin β 3 forward 5′-ACCTGCTTGCCCATGTTTG-3′ and reverse 5′-GCGGGTCACCTGGTCAGTTA-3′. All samples were analyzed in duplicate for each primer set. Gene expression levels were determined with the comparative ΔCt method using ARP as reference and the non-stimulated condition was set to 1. Relative expression levels are presented as mean ± S.D.
Lentiviral transduction
Constructs TRCN0000003234,TRCN0000003235, TRCN0000003236 and TRCN0000003237 from the Mission library (Sigma) were used to target integrin β 3 with construct SHC001 as a negative control. Cells were transduced in the presence of 4 μg/ml polybrene (Sigma) overnight. After recovery cells were selected and maintained in growth medium containing 0.5 μg/ml puromycin. For overexpression of integrin β 3 , M-IV cells were transduced with a lentiviral integrin β 3 expression construct [33] , kindly provided by Dr. Deborah Novack, Washington University, St. Louis, USA.
Statistical analysis
All results are expressed as the mean ± S.D. Statistical differences were examined by one-way ANOVA followed by Bonferroni's multiple comparison test. P<0.05 was considered as statistically significant.
Results
BMP-7 inhibits TGF-β-induced invasion
in the metastatic cell line M-IV, but not in the premalignant M-II cell line BMP-7 inhibits TGF-β-induced EMT of both normal breast cells [22] , as well as of invasive, osteotropic breast and prostate cancer cells, which is associated with inhibition of bone metastasis [23, 24] . To investigate whether BMP-7 also has an inhibitory effect on TGF-β-induced invasion, we analysed its effect on M-IV in a spheroid invasion assay. The response of this metastatic cell line was compared to a precursor cell line, the RAStransformed cell line M-II and not M-I, since RAS has been reported to enhance TGF-β-induced responses [34] . In the absence of TGF-β BMP-7 had no inhibitory effect on the invasion of M-II and M-IV cells, while TGF-β induced invasion of both cell types (Fig. 1a-d) . However, BMP-7 strongly inhibited the TGF-β-induced invasion of the metastatic M-IV cells, but not of the premalignant M-II cells (Fig. 1a-d ). This suggests that BMP-7 specifically inhibits TGF-β pro-invasive mechanisms exploited by metastatic cells.
BMP-7 does not affect proliferation in M-IV cells
To rule out that the observed effects of BMP-7 on TGF-β-induced invasion are due to effects on cell growth, we performed proliferation assays. As reported previously [25] , TGF-β has a minor growth-inhibitory effect on M-IV. BMP-7 on its own did not affect cell proliferation (Supplementary Figure 1) . BMP-7 also did not affect TGF-β-induced growth inhibition. Thus, the inhibitory effect of BMP-7 on TGF-β-induced invasion is not due to effects on the growth of these cells. 3.3 BMP-7, but not BMP-6, inhibits TGF-β-induced invasion in M-IV To assess whether other BMPs are capable of inhibiting TGF-β-induced invasion, we studied the effect of BMP-6, which is the closest homolog of BMP-7 and shares 73% identity on the amino acid level. In contrast to BMP-7, BMP-6 did not affect the TGF-β-induced invasion of M-IV cells, and also did not inhibit basal invasion. (Fig. 1e, f) . These data indicate that the ability of BMP-7 to inhibit TGF-β-induced invasion is specific for BMP-7.
Noggin induces invasion in M-IV through blocking of BMP-7
Previous studies of our group have shown that the basal invasion of M-IV cells is dependent on TGF-β-signaling [25] . However we did not observe an inhibitory effect of BMP-7 addition on the basal invasion (Fig. 1c, d ). One explanation for this might be that BMP-7 is already present at saturating levels under these conditions. Indeed, we found that M-IV cells express BMP-7 mRNA and that the horse serum used in the assays contained BMP-7 protein (data not shown). Therefore, we tested the effect of a natural antagonist of BMP-2, 4 and 7, Noggin. As shown in Fig. 2a and b, Noggin enhanced basal invasion 2.0-fold in M-IV. In the M-II cell line, in which TGF-β-induced invasion is not affected by BMP-7, addition of Noggin also had no effect on basal invasion (Supplementary Figure 2) . Thus, inhibition of BMP-2, 4 and 7 induces invasion in M-IV cells, but not in M-II cells.
Since Noggin inhibits BMP-2, 4 and 7, we next determined if blockade of BMP-7 can also induce basal invasion of M-IV cells. For this, we added BMP-7 neutralizing antibodies to the spheroid invasion system. These antibodies enhanced basal invasion 1.8-fold compared to the control antibody (Fig. 2c, d ). This indicates that the induction of invasion by Noggin is mainly due to inhibition of BMP-7. Moreover, it suggests that TGF-β and BMP-7 also antagonize each other under basal conditions. 3.5 Both BMP-6 and BMP-7 induce Smad signaling Next, we asked whether if the different effects of BMP-6 and BMP-7 on TGF-β-induced invasion in M-IV cells could be due to the possibility that BMP-7 is more potent in inducing BMP-signaling than BMP-6. To examine this, we analyzed activation of BMP-Smad signaling by two means. First, we analyzed whether BMP-6 and BMP-7 differ in their ability to induce phosphorylation of Smad1. However, Western blot analysis showed that Smad1 phosphorylation is induced to the same extent by both BMPs in M-IV cells, whereas the total levels of Smad1 were not affected (Fig. 3a) . Second, we investigated transcriptional activation of BMP-Smads, by using a luciferase-reporter driven by BMP Responsive Elements (BRE) [32] . Both BMP-6 and BMP-7 were found to activate the reporter ∼30 fold and thus efficiently induced BMP-Smad transcriptional activity in M-IV cells (Fig. 3b) . Taken together, these results indicate that BMP-6 and BMP-7 do not differ in their ability to induce Smad signaling in this cell line.
BMP-7 does not affect TGF-β-induced Smad signaling
To investigate the molecular mechanism by which BMP-7 inhibits TGF-β-induced invasion, we analyzed the effects of BMP-7 and BMP-6 on TGF-β Smad signaling. First, we analyzed whether BMP-7 had an inhibitory effect on the phosphorylation of Smad2. However, both BMP-7 and BMP-6 did not affect TGF-β-induced Smad2 phosphorylation (Fig. 3a) . Second, we studied the effect of BMP-7 on TGF-β-induced Smad3 transcriptional activity. To this end, we used a luciferase reporter containing 12 repeats of the Smad3 binding sequence CAGA [31] . TGF-β induced the activity of this reporter ∼55-fold, but both BMP-7 and BMP6 did not significantly affect the TGF-β-induced reporter activity (Fig. 3c) . Thus, BMP-7 has no effect on TGF-β-induced Smad signaling in M-IV cells.
BMP-7 inhibits TGFβ-induced integrin α v β 3 expression
We next examined the effect of BMP-7 on the expression of TGF-β target genes involved in invasion. As we previously identified a critical role for matrix metalloproteinase 2 (MMP2) in TGF-β-induced invasion [25] , we first analyzed if TGF-β-induced MMP2 expression is affected by BMP-7 in the spheroid model system. BMP-6 stimulation served as a negative control. However, as shown in Fig. 4a , BMP-7 (and BMP-6) did not affect TGF-β-induced expression of MMP2 in M-IV spheroids in collagen. Since integrin α v β 3 has recently been shown to enhance TGF-β-induced EMT and inhibition of integrin α v β 3 reduces metastasis [7] , we subsequently examined the expression of integrin α v and β 3 . Importantly, TGF-β potently induced the expression of both subunits in the collagen-embedded spheroids, and BMP-7, but not BMP-6, inhibited the TGF-β-induced expression of both α v and β 3 ( Fig. 4b and c) . Also, BMP-7 did not inhibit TGF-β-induced integrin α v and β 3 expression in M-II (Supplementary Figure 3a, b) . Thus, the inhibitory action of BMP-7 on TGF-β-induced collagen invasion of M-IV spheroids might be mediated through inhibition of TGF-β-induced integrin α v β 3 expression.
Integrin β 3 is necessary for TGF-β-induced invasion
To determine if integrin α v β 3 is important for TGF-β-induced invasion, we investigated if inhibition of α v integrins blocks TGF-β-induced invasion in the spheroid model system. For this, we used a non-peptide integrin inhibitor, GLPG0187. This molecule exhibits high affinitiy for α v β 1 , α v β 3 , α v β 5 , α v β 6 , α v β 8 as well as α 5 β 1 in in vitro competitive binding assays (Supplementary Table 1 ). Treatment of M-IV spheroids with GLPG0187 inhibited TGF-β-induced invasion (Fig. 5a, b) . This indicates that integrin α v β 3 could be necessary for TGF-β-induced invasion of M-IV cells.
To further establish if integrin β 3 is necessary for TGF-β-induced invasion, we performed RNAi-mediated knockdown experiments. M-IV cells were transduced with viruses encoding 4 different shRNA constructs against integrin β 3 . These constructs inhibited TGF-β-induced integrin β 3 expression at the mRNA level (Supplementary Figure 4a) . TGF-β-induced invasion was indeed inhibited by knockdown of integrin β 3 (Fig. 5c,d ), indicating that downregulation of integrin β 3 by BMP-7 contributes to BMP-7-mediated inhibition of invasion. Fig. 3 BMP-6 and BMP-7 induce BMP-Smad signaling, but do not affect TGF-β Smad signaling. a Cells were treated with the indicated ligands (BMP-6 and BMP-7 at 100 ng/ml, TGF-β at 5 ng/ml) for 15 min, lysed and subjected to SDS-PAGE and Western blotting. Blots were incubated with phospho-Smad2, phospho-Smad1 and Smad1 antibodies. Total ERK was used as a loading control. b Cells were transfected with the BRE-Luc reporter construct, starved and subsequently stimulated for 8 h with BMP-6 or 7 (both at 100 ng/ml). Relative luciferase activity (RLU) is expressed as mean ± S.D. of triplicate cultures. c Cells were transfected with the CAGA 12 -Luc reporter construct, starved and subsequently stimulated for 8 h with the indicated ligands (BMP-6 and BMP-7 at 100 ng/ml, TGF-β at 5 ng/ml). Relative luciferase activity (RLU) is expressed as mean ± S.D. of triplicate cultures. One representative out of at least three independent experiments is shown 3.9 Overexpression of integrin β 3 rescues TGF-β-induced invasion from BMP-7 inhibition
To demonstrate that the inhibition of integrin β 3 expression by BMP-7 is critical for the inhibition of TGF-β-induced invasion, we used a lentiviral vector that overexpresses integrin β 3 [33] . As shown in Supplementary Figure 4b , M-IV cells transduced with this virus exhibit higher levels of integrin β 3 protein compared to wildtype (WT) cells. The overexpression of integrin β 3 did not affect TGF-β-induced invasion, but completely counteracted the BMP-7 inhibitory effect (Fig. 6) . Taken together, these data suggest that BMP-7 inhibits TGF-β-induced invasion by inhibiting TGF-β-induced integrin β 3 expression.
Discussion
In order to understand how BMP-7 exerts its antimetastatic effects reported before [23, 24] , we investigated whether BMP-7 interferes with TGF-β-induced invasion of human breast cancer cells. We showed that BMP-7 inhibits TGF-β-induced invasion in the metastatic breast cancer cell line M-IV through inhibition of integrin β 3 expression. In addition, we showed that BMP-7 specifically inhibits the invasion of this metastatic cell line, and not the invasion of its premalignant precursor, M-II. Moreover, the inhibitory effect was specific for BMP-7, as its closest homolog, BMP-6 did not have any effect on TGF-β-induced invasion. To our knowledge, this is the first report that shows that BMP-7 inhibits TGF-β-induced invasion.
Since the antagonism between TGF-β and BMP-7 has been described before [22] [23] [24] [35] [36] [37] , the question arises whether the process that we describe occurs in other cell types as well. BMP-7 inhibits bone metastasis of the MDA-MB231 breast cancer cell line [23] and PC3 prostate cancer cell line [24] . However, in these cell lines BMP-7 inhibited TGF-β/Smad signaling [23, 24] , whereas under our experimental conditions we did not observe an inhibitory effect of BMP-7 on the TGF-β-Smad pathway. On the other hand, BMP-7 inhibited tumor progression of the uveal melanoma cell line OCM-1 without inhibiting the TGF-β-Smad pathway [37] . Thus, BMP-7 is able to inhibit the tumor-promoting effects of TGF-β through either Smad-and non-Smad-mechanisms, depending on the cellular context.
Our data indicate that the inhibitory effect of BMP-7 on breast cancer invasion in part can be explained by inhibition of TGF-β-induced expression of integrin β 3 . Integrin β 3 is induced by TGF-β and enhances EMT in a feed-forward loop by inducing Src [38] . It is therefore tempting to speculate that the inhibition of TGF-β-induced integrin β 3 expression by BMP-7 might also play a role in the observed antagonistic effects between TGF-β and BMP-7 in EMT.
As mentioned before we did not detect a significant effect of BMP-7 on TGF-β Smad signaling, although we have shown that TGF-β-induced invasion is dependent on Smad3 and Smad4 [25] . Since TGF-β-induced integrin β 3 expression has been reported to be dependent on p38, but not on Smads [39] , the inhibitory effect of BMP-7 on TGF-β-induced invasion might be mediated via non-Smad pathways. However, we could not find a significant effect of BMP-7 on (TGF-β-induced) p38 phosphorylation that could explain the inhibition of BMP-7 on TGF-β-induced integrin β 3 expression (data not shown). It is therefore likely that the effect is mainly due to BMP-7 transcriptional targets, such as transcription factors or microRNAs, that interfere with TGF-β-induced integrin β 3 expression. One striking finding is that BMP-7 is able to inhibit TGF-β-induced invasion, whereas BMP-6 is not, despite the fact that they share 73% amino acid homology and are able to bind to the same receptors [40] [41] [42] [43] . Generally, BMP-6 is regarded as more potent than BMP-7 in inducing bone differentiation [40, 44, 45] . However, BMP-7 is inhibited by Noggin, whereas BMP-6 is resistant to inhibition by Noggin due to an additional lysine at residue 60 [45] . On the other hand, we found that BMP-6 and BMP-7 induce Smad1 phosphorylation and BMP-Smad transcriptional activity to the same extent in MIV cells. Possibly, BMP-6 or BMP-7 have different effects on non-Smad signaling pathways. However, we did not observe any significant differences between BMP-7 and BMP-6 on (TGF-β-induced) p38 and ERK phosphorylation in MIV cells (data not shown).
BMP-7 did not inhibit TGF-β-induced invasion of the premalignant precursor cell line M-II. Interestingly, overexpression of a dominant-negative TGF-β-receptor also had differential effects on these two cell lines in vivo [46] . It is likely that upon tumor progression the response to TGF-β is altered in such a manner that BMP-7 is able to inhibit certain TGF-β responses. On the genetic level M-IV has an extra copy of the long arm of chromosome 1, a type of alteration often observed in breast cancer [29] . A detailed survey of the genetic changes in the MCF10A series of cell lines revealed several genetic changes in M-IV compared to M-II, as well as differences in global gene expression [47] . It is likely that the ability of BMP-7 to inhibit TGF-β-induced invasion is highly dependent on these additional genetic changes.
In conclusion, we have shown that BMP-7 inhibits TGF-β-induced invasion through inhibition of TGF-β-mediated integrin β 3 expression. These data reinforce the rationale to either use BMP-7 or target integrin β 3 in breast cancer metastasis.
